Edwards Lifesciences Non-GAAP EPS of $0.78 beats by $0.04, revenue of $1.74B beats by $40M
Seeking Alpha ·
Edwards Lifesciences press release ( EW ): Q2 Non-GAAP EPS of $0.78 beats by $0.04 . Revenue of $1.74B (+13.7% Y/Y) beats by $40M . Based on the company’s second quarter performance, Edwards is increasing its full-year 2026 sales growth rate guidance to 10% to 11% from
DYAX Investor Sentiment
Bullish (Long) 60% · Bearish (Short) 40%
467 participants
Related News
- U.S. Century Bank GAAP EPS of $0.49 in-line, revenue of $27.95M beats by $1.21M
- CNB Financial Non-GAAP EPS of $0.63, revenue of $87.6M
- Pentagon awards Oracle nearly $7 billion deal in latest software consolidation push
- EastGroup signals $325M 2026 development starts as it raises FFO midpoint to $9.59 per share
- Ladder plans $500M loan pipeline as it expects net portfolio growth through 2026
- Waste Connections outlines 2026 revenue of $10.02B-$10.05B as fuel spikes and commodities improve
